ICYMI, some of this week’s featured content includes a new episode of The Cutaneous Connection podcast. Plus, stories on emerging topicals and biologics for atopic dermatitis, eye issue treatments, masculinizing hormone therapy and acne diagnosis, and more.
This week’s edition of The Mainstream Patient features stories on castor oil for hair growth, skin picking, reef safe sunscreens, biotin for acne, plus more.
Ava Shamban, MD, discusses microneedling differentiators using the Vivace Microneedle RF device, combination therapies, and the importance of social media partnerships.
A cohort study investigated the association between MHT and acne diagnosis.
Novel biologics are moving into off-label indications to expand the dermatologic armamentarium for a broad range of inflammatory skin diseases.
A study examined the difference in prescribing patterns between pediatricians and dermatologists when it came to acne treatments.
In this month's Legal Eagle article, David J. Goldberg, MD, JD, examines physicians being sued for using injectables for off-label procedures, such as for oily skin.
Dermatologists have a variety of topicals to choose from, but other options are on the horizon to add to this armamentarium.
In this episode, we take a look back at what happened at the American Academy of Dermatology Virtual Meeting Experience 2021 (AAD VMX 2021), including exclusive interviews with two KOLs about their presentations regarding climate change and new data on biologics for psoriasis.
In this month's Cosmetic Conundrums column, Chief Medical Editor of Dermatology Times®, Zoe Diana Draelos, MD, answers a few common questions on how to treat eye issues.
A new generation of inhibitors take aim at key sources of inflammation.
Prescribing biologics can require a complex approval and claims process. Creating a tiered system based on office workload can help practices understand and allocate staff time. Outsourcing approvals to pharmacies where possible can also streamline the process.